Bayer launches over-the-counter Aleve TENS pain device

Bayer (ETR:BAYN) said today it launched the Aleve direct therapy targeted transcutaneous electrical nerve stimulation pain relief device in the U.S. The device is designed as a non-invasive, drug-free method of pain control, specifically targeted at lower back pain, according to the company. “Aleve Direct Therapy puts controllable TENS technology in consumers hands without having to visit the doctor. It provides high intensity of power and its wireless remote control makes it easy to adjust the power of intensity to fit the user’s needs. We are pleased to be able to provide this safe, drug-free and convenient self-care option to help consumers get the relief they need from lower back pain,” U.S. medical affairs veep Andre Schmidt said in a press release. The device is indicated for the temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities, the company said, and is regulated as an FDA-cleared Class II medical device. “For people suffering from lower back pain the availability of the Aleve Direct Therapy TENS Device is good news. The device provides drug-free, deep penetrating lower-back pain relief, without a prescription,” consumer health division veep Fred Duchin said in prepared remarks. In January, Panasonic (NYSE:PC) closed its $1 billion buy of Bayer’s diabetes care business. The diabetes care business will operate as a stand alone c...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Pain Management Bayer HealthCare Source Type: news